CSTL
Castle Biosciences, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$32.91
+0.80%Leverage
- Debt / equity
- 0.08x
- Net debt / equity
- -0.05x
- Debt / assets
- 0.07x
- Debt / EBITDA
- -11.33x
- Net debt / EBITDA
- 7.87x
Liquidity & coverage
- Current ratio
- 6.04x
- Quick ratio
- 5.85x
- Cash ratio
- 4.72x
- Interest coverage
- -85.62x
- EBITDA / interest
- -8.63x
- Working capital
- $284.6M
Cash & dividend
- FCF / debt
- -0.01x
- Cash flow / debt
- 1.16x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026